Culture Collections

General Cell Collection Detail

ECACC General Cell Collection: BEAS-2B

Supplied by: European Collection of Authenticated Cell Cultures (ECACC)
Culture Type: Cell line
Collection: ECACC General Collection
Catalogue No.: 95102433
Cell Line Name: BEAS-2B
Other Collection No.: ATCC CRL-9609
Citation Guidance: If use of this culture results in a scientific publication, it should be cited in the publication as: BEAS-2B (ECACC 95102433)
Keywords: Human bronchial epithelium, normal
Cell Line Description: BEAS-2B cells were derived from normal bronchial epithelium obtained from autopsy of non-cancerous individuals. Cells were infected with a replication-defective SV40/adenovirus 12 hybrid and cloned. Squamous differentiation can be observed in response to serum. This ability can be used for screening chemical and biological agents inducing or affecting differentiation and/or carcinogenesis. The cell line has been applied for studies of pneumococcal infection mechanisms. BEAS-2B was described to express keratins and SV40 T antigen. Subculturing the cells before confluency is necessary as confluent cultures rapidly undergo squamous terminal differentiation. This material is cited in a U.S and / or other Patent (U.S. Pat. 4,885,238) and may not be used to infringe the patent claims.
Species: Human
Tissue of Origin: Lung
CellType: Epithelial-like
Growth Mode: Adherent
DNA Profile: STR-PCR Data:

Amelogenin: X,Y
CSF1PO: 9,12
D13S317: 13
D16S539: 12
D5S818: 12,13
D7S820: 10,13
THO1: 7,9.3
TPOX: 6,11
vWA: 17,18

Karyotype: Not specified
GMO Status: Genetically Modified Organism Class 1 (GMO1)
Biosafety Information: Unless specified otherwise, at the European Collection of Authenticated Cell Cultures (ECACC) we routinely handle all of our cell lines at containment level 2 in accordance with the ACDP guidelines. ACDP = Advisory Committee on Dangerous Pathogens (UK)
All cell cultures have the potential to carry as yet unidentified adventitious agents. It is the responsibility of the end user to ensure that their facilities comply with biosafety regulations for their own country.

ACDP Guidance: Biological agents: Managing the risks in laboratories and healthcare premises.

Hyperlinks to MSDS documents:
Frozen cell cultures Material Safety Data Sheet
Growing cell cultures Material Safety Data Sheet
Nucleic acids derived from cell cultures Material Safety Data Sheet
Subculture Routine: A centrifugation step to remove the cryoprotectant is essential. Rapidly thaw the frozen ampoule in a water bath at 37°C for 1-2 minutes. Transfer the contents to a centrifuge tube and slowly add 5-10ml of pre-warmed growth media. Remove a sample for counting. Centrifuge at 100-150g for 2-3 minutes to pellet cells and seed at10, 000 cells per cm². Check cultures daily  and passage sub-confluent cultures (maximum 70% confluence )using 0.25% trypsin or trypsin/EDTA. Incubate at room temperature for 5-10 min until cells detach. Add fresh medium and disperse cells, centrifuge and resuspend pellet in medium. Seed into new flasks between 3000 and 10, 000 cells per cm². Flasks have to be precoated with a mixture of 0.01 mg/ml fibronectin, 0.03 mg/ml collagen and 0.01 mg/ml bovine serum albumin dissolved in BEGM. Add mixture at ratio of 0.2 ml per cm² surface area. Incubate at 37°C for at least 6 hours 5% CO2. Remove excess fluid and allow flasks to dry by incubating at 37°C overnight, leaving the caps loose. Prior to addition of cells wash flask three times with PBS. Note: BEGM medium is almost serum-free, therefore trypsin inhibitor is essential. Add an equal or greater volume of trypsin inhibitor as trypsin used, centrifuge and reseed cells in collagen coated flasks using culture medium.

When freezing cells down use 50:50 fresh culture medium:conditioned medium plus 10% DMSO


Culture Medium: BEGM, also known as LHC-9 with modification (available from Clonetics Corporation, CC3171 (BEBM) plus additives CC4175 or BEGM Bullet Kit, CC3170); Note: Additives supplied contain gentamycin which has been omitted for culture at ECACC; media is serum-free.
Depositor: Obtained from ATCC
Originator: No
Country: USA
References: J. Tissue Culture Methods 1985; 9:43 Infect Immun 1998; 66:820 J In Vitro Toxicology 1997; 10:93 J In Vitro Toxicology 1997; 10:85
Additional Bibliography: Not specified
Patents: None specified by Depositor
Release Conditions: No

product imagesProduct Images

Note: Links open in a new window

product documentsProduct Documents

Note: Links open in a new window

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.

Available Formats

DNA-5µg (100ng/µl)
RNA-5µg (100ng/µl)

  • Frozen
  • DNA-5µg (100ng/µl)
  • RNA-5µg (100ng/µl)
  • cDNA-20µl

This product is only available through your local distributor.

Back to top
Copyright © Public Health England.

Please confirm your country of origin from the list below.